José Gómez

José Gómez is a distinguished author and thought leader in the fields of new technologies and fintech. He holds a Master's degree in Financial Technology from the prestigious Berkley School of Business, where he honed his expertise in digital finance and innovative technologies. With over a decade of experience in the financial sector, José has worked at Momentum Corp, a leading company specializing in financial solutions and technology development. His writings provide incisive analyses on the intersection of finance and technology, offering readers a comprehensive understanding of emerging trends and their implications for the industry. José’s passion for educating and informing others is evident in his insightful articles and thought-provoking publications.

High-definition, realistic image of a significant coaching change impacting a renowned city basketball team, showing a press conference with new and old coaching staff, players, reporters, and all the emotions involved.

Massive Coaching Change Shakes the Atlanta Dream

A significant shift has occurred in the world of women’s basketball as a celebrated coach takes the reins of the Atlanta Dream. Originating from Bath, Ohio, the new head coach, Smesko, is renowned for establishing a formidable women’s basketball program at FGCU
13 November 2024
A high-definition, realistic image illustrating a conceptual interpretation of the upcoming CPI (Consumer Price Index) release. The scene may include elements to represent economic indicators, such as line graphs indicating price changes, clocks representing time, and newspapers with headlines related to inflation or consumer trends. Perhaps there is also a globe or world map on one side, emphasizing the global relevance and impact of this data. The color palette could be composed of subtle, professional tones, suggesting a serious, economic theme.

What You Need to Know About the Upcoming CPI Release

The Consumer Price Index (CPI) is an essential economic indicator that tracks the prices of goods and services, reflecting how much consumers are spending. Each month, economists eagerly await its release, as it provides critical insights into inflation trends and purchasing behaviors.
13 November 2024
A realistic high-definition image showcasing the untold struggles of an aspiring Olympic athlete. The scene depicts a determined, hardworking individual, let's say a black female mid-distance runner, during their grueling training regime. She is seen running on a track, her face etched with determination and fatigue, embodying dedication and resilience. The setting sun forms the backdrop, symbolizing the nearing of her dream. Around her, visual indications of her struggles such as worn-out running shoes, empty water bottles, and a stopwatch exhibit her arduous journey towards her Olympic dream.

The Untold Struggles of an Olympic Dreamer

At 33, Chari Hawkins reached what felt like an unattainable milestone: she qualified for the U.S. Olympic team. Excitement filled the air as she arrived in Paris, overwhelmed by the thought of competing on such a grand stage. However, her high spirits
13 November 2024
Realistically designed, high-definition image of a newspaper headline reading 'Injury Update: Basketball Player from Professional Team Pelicans Faces Uncertain Future'

Injury Update: Pelicans Star Faces Uncertain Future

The New Orleans Pelicans received troubling news as one of their brightest stars is now sidelined. Zion Williamson has been diagnosed with a left hamstring strain and his absence from the lineup remains indefinite. This comes as a significant blow to the
13 November 2024
An image showing a symbolic representation of the end of ambitions in the neuroscience field. It could be a laboratory with abandoned neuroscience research equipment and paperwork, or a metaphorical image of a human brain overlaid with a 'closed' sign.

Is This the End of AbbVie’s Neuroscience Aspirations?

Despite some recent setbacks, AbbVie remains committed to its journey in neuroscience, marking the beginning of a new chapter in its drug development efforts. Over the past week, the company faced disappointing results when a key schizophrenia medication failed to outperform a
12 November 2024
1 11 12 13 14 15 31